Association between hepatitis B and metabolic syndrome: Current state of the art

World Journal of Gastroenterology

Volumn 22, Issue 1, 2016, Pages 155-164

  Jarcuska, Peter ^a   Drazilova, Sylvia ^b   Fedacko, Jan ^a   Pella, Daniel ^a   Janicko, Martin ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b Hospital in Poprad   (Slovakia)

Author keywords

Cirrhosis; Fibrosis; Hepatitis B; Hepatocellular carcinoma; Metabolic syndrome; Nonalcoholic fatty liver disease

Indexed keywords

LIPOPROTEIN;

ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREVALENCE; REVIEW; RISK ASSESSMENT; VIRUS LOAD; COMPLICATION; DIABETES COMPLICATIONS; HEPATITIS B, CHRONIC; LIVER TUMOR; RISK FACTOR; VIROLOGY;

ATHEROSCLEROSIS; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; HEPATITIS B, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK FACTORS; VIRAL LOAD;

EID: 84953372545     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i1.155     Document Type: Review

References (78)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539 [PMID: 17256718]
2. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13 Suppl 1: S47-S49 [PMID: 7571830]
3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480 [PMID: 16681555]
4. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-391 [PMID: 11927499]
5. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121 [PMID: 18505690 DOI: 10.1053/j.gastro.2008.03.073]
6. Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, Huang CC, Yen MF, Chen TH. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) 2006; 30: 794-799 [PMID: 16404404]
7. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta 2007; 380: 238-240 [PMID: 17316590]
8. Wong VW, Wong GL, Chu WC, Chim AM, Ong A, Yeung DK, Yiu KK, Chu SH, Chan HY, Woo J, Chan FK, Chan HL. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 2012; 56: 533-540 [PMID: 22027575 DOI: 10.1016/j.jhep.2011.09.013]
9. Li WC, Lee YY, Chen IC, Sun C, Chiu FH, Chuang CH. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Liver Int 2013; 33: 1194-1202 [PMID: 23782533 DOI: 10.1111/liv.12224]
10. Chung TH, Kim MC, Kim CS. Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome. Korean J Fam Med 2014; 35: 81-89 [PMID: 24724003 DOI: 10.4082/kjfm.2014.35.2.81]
11. Jinjuvadia R, Liangpunsakul S. Association between metabolic syndrome and its individual components with viral hepatitis B. Am J Med Sci 2014; 347: 23-27 [PMID: 23514672 DOI: 10.1097/MAJ.0b013e31828b25a5]
12. Zhou Y, Cui Y, Deng H, Yu J. Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China. BMC Public Health 2014; 14: 516 [PMID: 24885963 DOI: 10.1186/1471-2458-14-516]
13. Jaru͉ka P, Janiko M, Kruzliak P, Novák M, Veselíny E, Fedako J, Senajová G, Drazilová S, Madarasová-Gecková A, Mareková M, Pella D, Siegfried L, Kristián P, Kolesárová E. Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study. Eur J Intern Med 2014; 25: 286-291 [PMID: 24445023 DOI: 10.1016/j.ejim.2014.01.006]
14. Janicko M, Senajová G, Drazilová S, Veselíny E, Fedacko J, Siegfried L, Kristian P, Virág L, Pella D, Mareková M, Gecková AM, Kalanin P, Jarcuska P, Halánová M. Association between metabolic syndrome and hepatitis B virus infection in the Roma population in eastern Slovakia: a population-based study. Cent Eur J Public Health 2014; 22 Suppl: S37-S42 [PMID: 24847613]
15. Choi JS, Han KJ, Lee S, Chun SW, Kim DJ, Kim HC, Kim HM. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men. J Epidemiol 2015; 25: 74-79 [PMID: 25283312 DOI: 10.2188/jea. JE20140053]
16. Do S. The natural history of hepatitis B in Asian Americans. Asian Am Pac Isl J Health 2001; 9: 141-153 [PMID: 11846360]
17. Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: fact or fiction? J Gastroenterol Hepatol 2015; 30: 14-20 [PMID: 25092429 DOI: 10.1111/jgh.12700]
18. Yen SL, Chiu TY, Lin YC, Lee YC, Lee LT, Huang KC. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes (Lond) 2008; 32: 474-480 [PMID: 17955029]
19. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc 2004; 103: 286-291 [PMID: 15175824]
20. Chen JY, Wang JH, Lin CY, Chen PF, Tseng PL, Chen CH, Chang KC, Tsai LS, Chen SC, Lu SN. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. J Gastroenterol Hepatol 2010; 25: 1763-1768 [PMID: 21039839 DOI: 10.1111/j.1440-1746.2010.06300.x]
21. Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat 2012; 19: e48-e57 [PMID: 22239526 DOI: 10.1111/j.1365-2893.2011.01535.x]
22. Liu PT, Hwang AC, Chen JD. Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia. Metabolism 2013; 62: 220-225 [PMID: 22938729]
23. Wang CH, Chen CJ, Lee MH, Yang HI, Hsiao CK. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan. Atherosclerosis 2010; 211: 624-629 [PMID: 20359711]
24. Hajjou M, Norel R, Carver R, Marion P, Cullen J, Rogler LE, Rogler CE. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol 2005; 77: 57-65 [PMID: 16032730]
25. Norton PA, Gong Q, Mehta AS, Lu X, Block TM. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol 2003; 77: 5503-5506 [PMID: 12692252]
26. Neurath AR, Strick N. The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV. Virology 1994; 204: 475-477 [PMID: 8091682]
27. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125: 1695-1704 [PMID: 14724822]
28. Romero-Gómez M, Del Mar Viloria M, Andrade RJ, Salmerón J, Diago M, Fernández-Rodríguez CM, Corpas R, Cruz M, Grande L, Vázquez L, Muñoz-De-Rueda P, López-Serrano P, Gila A, Gutiérrez ML, Pérez C, Ruiz-Extremera A, Suárez E, Castillo J. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128: 636-641 [PMID: 15765399]
29. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008; 23: 779-782 [PMID: 18028349]
30. Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, Cheong J, Jeong DW, Lee YH, Cho YH, Bae MJ, Choi EJ. Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol 2012; 18: 6120-6126 [PMID: 23155341 DOI: 10.3748/wjg.v18.i42.6120]
31. Zhang J, Shen Y, Cai H, Liu YM, Qin G. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A metaanalysis. Hepatol Res 2015; Epub ahead of print [PMID: 25601609 DOI: 10.1111/hepr.12481]
32. Shen Y, Zhang J, Cai H, Shao JG, Zhang YY, Liu YM, Qin G, Qin Y. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls. BMC Gastroenterol 2015; 15: 32 [PMID: 25887997 DOI: 10.1186/s12876-015-0263-9]
33. Bogdanova K, Poczatkova H, Uherkova L, Riegrova D, Rypka M, Feher J, Marchesini G, Vesely J. Non-Alcoholic fatty liver disease (NAFLD)-A novel common aspect of the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150: 101-104 [PMID: 16936910]
34. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
35. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Prevalence and risk factors of non-Alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244 [PMID: 17400323]
36. McCullogh AJ. Natural history of nonalcoholic steatohepatitis. In: Arroyo V, Forns X, Garcia-Pagán JC, Rodés. Progress in the Treatment of Liver Diseases. Barcelona: Ars medica, 2003: 219-225
37. Jarcuska P, Janicko M, Drazilová S, Senajová G, Veselíny E, Fedacko J, Siegfried L, Kristian P, Tkác M, Pella D, Mareková M, Gecková AM, Jarcuska P. Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study. Cent Eur J Public Health 2014; 22 Suppl: S43-S50 [PMID: 24847614]
38. Hashimoto E, Tokushige K, Farrell GC. Histological features of non-Alcoholic fatty liver disease: what is important? J Gastroenterol Hepatol 2012; 27: 5-7 [PMID: 22188024 DOI: 10.1111/j.1440-1746.2011.06957.x]
39. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 2011; 53: 190-195 [PMID: 21788761 DOI: 10.1097/MPG.0b013e31821b4b61]
40. Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 2008; 47: 1513-1523 [PMID: 18393289]
41. Jarcuska P, Janicko M, Veselíny E, Jarcuska P, Skladaný L. Circulating markers of liver fibrosis progression. Clin Chim Acta 2010; 411: 1009-1017 [PMID: 20399764 DOI: 10.1016/j.cca.2010.04.009]
42. Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, Lee FY, Wu JC. Inverse association between hepatitis B virus infection and fatty liver disease: a largescale study in populations seeking for check-up. PLoS One 2013; 8: e72049 [PMID: 23991037 DOI: 10.1371/journal.pone.0072049]
43. Xu QH, Jie YS, Shu X, Chen LB, Cao H, Li G. Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009; 23: 141-143 [PMID: 20104761]
44. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-Analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011; 26: 1361-1367 [PMID: 21649726 DOI: 10.1111/j.1440-1746.2011.06801.x]
45. Zheng RD, Xu CR, Jiang L, Dou AX, Zhou K, Lu LG. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. Int J Med Sci 2010; 7: 272-277 [PMID: 20714438]
46. Peng D, Han Y, Ding H, Wei L. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol 2008; 23: 1082-1088 [PMID: 18707599 DOI: 10.1111/j.1440-1746.2008.05478.x]
47. Chiang CH, Huang KC. Association between metabolic factors and chronic hepatitis B virus infection. World J Gastroenterol 2014; 20: 7213-7216 [PMID: 24966591 DOI: 10.3748/wjg.v20. i23.7213]
48. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686 [PMID: 16530509]
49. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73 [PMID: 16391218]
50. Minakari M, Molaei M, Shalmani HM, Mohammad Alizadeh AH, Jazi AH, Naderi N, Shavakhi A, Mashayekhi R, Zali MR. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur J Gastroenterol Hepatol 2009; 21: 512-516 [PMID: 19190500 DOI: 10.1097/MEG.0b013e328326792e]
51. Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, Wang H, Farrell GC. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008; 23: 1419-1425 [PMID: 18853998 DOI: 10.1111/j.1440-1746.2008.05531.x]
52. Rastogi A, Sakhuja P, Kumar A, Hissar S, Jain A, Gondal R, Sarin SK. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol 2011; 54: 454-459 [PMID: 21934202 DOI: 10.4103/0377-4929.85074]
53. Chiang CH, Lai JS, Sheu JC, Yen LL, Liu CJ, Huang KC. The risky body mass index ranges for significant hepatitis B viral load: A campus-based study. Obes Res Clin Pract 2012; 6: e1-e90 [PMID: 24331171 DOI: 10.1016/j.orcp.2011.04.005]
54. Mohamadkhani A, Sayemiri K, Ghanbari R, Elahi E, Poustchi H, Montazeri G. The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Virol J 2010; 7: 228 [PMID: 20840785 DOI: 10.1186/1743-422X-7-228]
55. Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, You SL, Su J, Iloeje UH, Chen CJ. Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond) 2013; 37: 410-415 [PMID: 22531094 DOI: 10.1038/ijo.2012.63]
56. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511 [PMID: 12551878]
57. Moritani M, Adachi K, Arima N, Takashima T, Miyaoka Y, Niigaki M, Furuta K, Sato S, Kinoshita Y. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol 2005; 40: 1049-1053 [PMID: 16322949]
58. Yang KC, Chen MF, Su TC, Jeng JS, Hwang BS, Lin LY, Liau CS, Lee YT. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis 2007; 195: 392-397 [PMID: 17134707]
59. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 2005; 11: 1292-1296 [PMID: 15761966 DOI: 10.3748/wjg.v11.i9.1292]
60. Amirzadegan A, Davoodi G, Boroumand MA, Darabyan S, Dehkordi MR, Goodarzynejad H. Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J Med Sci 2007; 61: 648-655 [PMID: 18174634]
61. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-Alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007; 46: 1126-1132 [PMID: 17335930]
62. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit 2010; 16: CR202-CR205 [PMID: 20357720]
63. Kim JT, Park MS, Nam TS, Choi SM, Lee SH, Kim BC, Kim MK, Cho KH. Multiple cerebral arterial stenosis associated with hepatitis B virus infection. J Clin Neurol 2011; 7: 40-42 [PMID: 21519526 DOI: 10.3988/jcn.2011.7.1.40]
64. Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, Younossi ZM. Impact of non-Alcoholic fatty liver disease on chronic hepatitis B. Liver Int 2007; 27: 607-611 [PMID: 17498244]
65. Mena A, Pedreira JD, Castro A, López S, Vázquez P, Poveda E. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol 2014; 29: 173-178 [PMID: 24219115 DOI: 10.1111/jgh.12432]
66. Wong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, Chan HY, Tse CH, Wong VW. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B-A prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther 2014; 39: 883-893 [PMID: 24612251 DOI: 10.1111/apt.12658]
67. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117 [PMID: 18832522 DOI: 10.1136/gut.2008.157735]
68. Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, Yang SS, Kao JH. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clin Infect Dis 2013; 57: 1695-1702 [PMID: 24051864 DOI: 10.1093/cid/cit603]
69. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010; 59: 1410-1415 [PMID: 20660697 DOI: 10.1136/gut.2010.213553]
70. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, Tsai KS, Chen CJ. Body-mass index and progression of hepatitis B: a populationbased cohort study in men. J Clin Oncol 2008; 26: 5576-5582 [PMID: 18955457 DOI: 10.1200/JCO.2008.16.1075]
71. Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr J 2011; 10: 49 [PMID: 21569630 DOI: 10.1186/1475-2891-10-49]
72. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011; 54: 463-471 [PMID: 21538440 DOI: 10.1002/hep.24397]
73. Mihaila RG, Nedelcu L, Fratila O, Rezi EC, Domnariu C, Deac M. Effects of lovastatin and pentoxyphyllin in nonalcoholic steatohepatitis. Hepatogastroenterology 2009; 56: 1117-1121 [PMID: 19760953]
74. Rao GA, Pandya PK. Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology 2011; 140: 144-152 [PMID: 20833169 DOI: 10.1053/j.gastro.2010.08.055]
75. Lin YL, Shiao MS, Mettling C, Chou CK. Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. Virology 2003; 314: 253-260 [PMID: 14517078]
76. Bader T, Korba B. Simvastatin potentiates the anti-hepatitis B virus activity of FDA-Approved nucleoside analogue inhibitors in vitro. Antiviral Res 2010; 86: 241-245 [PMID: 20211652 DOI: 10.1016/j.antiviral.2010.02.325]
77. Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012; 30: 623-630 [PMID: 22271485 DOI: 10.1200/JCO.2011.36.0917]
78. Chen CI, Kuan CF, Fang YA, Liu SH, Liu JC, Wu LL, Chang CJ, Yang HC, Hwang J, Miser JS, Wu SY. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. Medicine (Baltimore) 2015; 94: e462 [PMID: 25674734 DOI: 10.1097/MD.0000000000000462]